BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28478906)

  • 1. [Ecology and fluoroquinolon resistance profiles in febrile urinary tract infections (FUTI) after prostate needle biopsy: A retrospective study in 466 biopsies].
    Duboureau H; Achkar K; Stephan R; Schmit JL; Saint F
    Prog Urol; 2017 May; 27(6):345-350. PubMed ID: 28478906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of fluoroquinolone-resistant Escherichia coli before and incidence of acute bacterial prostatitis after prostate biopsy.
    Minamida S; Satoh T; Tabata K; Kimura M; Tsumura H; Kurosaka S; Matsumoto K; Fujita T; Iwamura M; Baba S
    Urology; 2011 Dec; 78(6):1235-9. PubMed ID: 21908030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial comment. Sepsis due to fluoroquinolone-resistant Escherichia coli after transrectal ultrasound-guided prostate needle biopsy.
    Hernandez-Graulau JM
    Urology; 2009 Aug; 74(2):338-9; author reply 339. PubMed ID: 19646618
    [No Abstract]   [Full Text] [Related]  

  • 4. Sepsis due to fluoroquinolone-resistant Escherichia coli after transrectal ultrasound-guided prostate needle biopsy.
    Young JL; Liss MA; Szabo RJ
    Urology; 2009 Aug; 74(2):332-8. PubMed ID: 19464041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute bacterial prostatitis after transrectal ultrasound-guided prostate biopsy: epidemiological, bacteria and treatment patterns from a 4-year prospective study.
    Campeggi A; Ouzaid I; Xylinas E; Lesprit P; Hoznek A; Vordos D; Abbou CC; Salomon L; de la Taille A
    Int J Urol; 2014 Feb; 21(2):152-5. PubMed ID: 23906113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outbreak of fluoroquinolone-resistant Escherichia coli infections after transrectal ultrasound-guided biopsy of the prostate.
    Dumford D; Suwantarat N; Bhasker V; Kundrapu S; Zabarsky TF; Drawz P; Zhu H; Donskey CJ
    Infect Control Hosp Epidemiol; 2013 Mar; 34(3):269-73. PubMed ID: 23388361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of fluoroquinolone-resistant Escherichia coli as cause of postprostate biopsy infection: implications for prophylaxis and treatment.
    Zaytoun OM; Vargo EH; Rajan R; Berglund R; Gordon S; Jones JS
    Urology; 2011 May; 77(5):1035-41. PubMed ID: 21420152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levofloxacin resistant Escherichia coli sepsis following an ultrasound-guided transrectal prostate biopsy: report of four cases and review of the literature.
    Miura T; Tanaka K; Shigemura K; Nakano Y; Takenaka A; Fujisawa M
    Int J Urol; 2008 May; 15(5):457-9. PubMed ID: 18452466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of acute prostatitis caused by extended-spectrum beta-lactamase-producing Escherichia coli after transrectal prostate biopsy.
    Ozden E; Bostanci Y; Yakupoglu KY; Akdeniz E; Yilmaz AF; Tulek N; Sarikaya S
    Urology; 2009 Jul; 74(1):119-23. PubMed ID: 19464043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance to fluoroquinolones and treatment failure/short-term relapse of community-acquired urinary tract infections caused by Escherichia coli.
    Gagliotti C; Buttazzi R; Sforza S; Moro ML;
    J Infect; 2008 Sep; 57(3):179-84. PubMed ID: 18707763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adding amikacin to fluoroquinolone-based antimicrobial prophylaxis reduces prostate biopsy infection rates.
    Batura D; Rao GG; Bo Nielsen P; Charlett A
    BJU Int; 2011 Mar; 107(5):760-764. PubMed ID: 21029317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy.
    Taylor S; Margolick J; Abughosh Z; Goldenberg SL; Lange D; Bowie WR; Bell R; Roscoe D; Machan L; Black P
    BJU Int; 2013 May; 111(6):946-53. PubMed ID: 23464844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Febrile reactions after transrectal ultrasound-guided prostatic biopsy: a retrospective study.
    Hedelin H; Claesson BE; Wilpart A
    Scand J Urol Nephrol; 2011 Dec; 45(6):393-6. PubMed ID: 21679017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Empirical management of urinary tract infections complicating transrectal ultrasound guided prostate biopsy.
    Tal R; Livne PM; Lask DM; Baniel J
    J Urol; 2003 May; 169(5):1762-5. PubMed ID: 12686828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rising incidence of acute prostatitis following prostate biopsy: fluoroquinolone resistance and exposure is a significant risk factor.
    Mosharafa AA; Torky MH; El Said WM; Meshref A
    Urology; 2011 Sep; 78(3):511-4. PubMed ID: 21782225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bacteriological analysis of more than 600 febrile urinary infections managed in a community health network].
    Bruyère F; Vidoni M; Péan Y; Ruimy JA; Elfassi R
    Prog Urol; 2013 Sep; 23(10):890-8. PubMed ID: 24034802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoroquinolone-resistant acute prostatitis requiring hospitalization after transrectal prostate biopsy: effect of previous fluoroquinolone use as prophylaxis or long-term treatment.
    Ekici S; Cengiz M; Turan G; Alış EE
    Int Urol Nephrol; 2012 Feb; 44(1):19-27. PubMed ID: 21547465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of antimicrobial prophylaxis based on rectal culture results to prevent fluoroquinolone-resistant Escherichia coli infections after prostate biopsy.
    Suwantarat N; Dumford DM; Ponce-Terashima R; Kundrapu S; Zabarsky TF; Zhu H; Donskey CJ
    Infect Control Hosp Epidemiol; 2013 Sep; 34(9):973-6. PubMed ID: 23917913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The incidence of fluoroquinolone resistant infections after prostate biopsy--are fluoroquinolones still effective prophylaxis?
    Feliciano J; Teper E; Ferrandino M; Macchia RJ; Blank W; Grunberger I; Colon I
    J Urol; 2008 Mar; 179(3):952-5; discussion 955. PubMed ID: 18207185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy.
    Liss MA; Chang A; Santos R; Nakama-Peeples A; Peterson EM; Osann K; Billimek J; Szabo RJ; Dash A
    J Urol; 2011 Apr; 185(4):1283-8. PubMed ID: 21334021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.